C917 | T-¼¼Æ÷ ´ë °ú¸³»ó ¸²ÇÁ±¸¼º ¹éÇ÷º´(·ù¸¶Æ¼½º°üÀý¿° °ü·Ã) | T-cell large granular lymphocytic leukaemia(associated with rheumatoid arthritis) |
|
C918 | ¼º¼÷ B-¼¼Æ÷¹éÇ÷º´, ¹öŶº´ | Mature B-cell leukaemia Burkitt-type |
|
C919 | »ó¼¼ºÒ¸íÀÇ ¸²ÇÁ¼º ¹éÇ÷º´ | Lymphoid leukemia, unspecified |
|
C92 | °ñ¼ö¼º ¹éÇ÷º´ | Myeloid leukemia |
|
C92 | °ú¸³±¸¼º ¹éÇ÷º´ | Granulocytic leukemia |
|
C92 | °ñ¼ö¼º ¹éÇ÷º´ | Myelogenous leukemia |
|
C920 | ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´[AML] | Acute myeloblastic leukemia[AML] |
|
C9200 | t(8:21)À» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ | AML with t(8:21) |
|
C9200 | AML1/ETO | AML1/ETO |
|
C9201 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, inv(16)(p13:q22) | Acute myeloid leukaemia, inv(16)(p13:q22) |
|
C9201 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, t(16:16)(p13:q11) | Acute myeloid leukaemia, t(16:16)(p13:q11) |
|
C9201 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, CBF-beta/MYH11 | Acute myeloid leukaemia, CBF-beta/MYH11 |
|
C9208 | ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´[AML] | Other and inspecigied acute myeloblastic leukaemia [AML] |
|
C9208 | ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´, ÃÖ¼ÒºÐÈ | Acute myeloblastic leukaemia, minimal differentiation |
|
C9208 | ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´(¼º¼÷À» µ¿¹ÝÇÑ) | Acute myeloblastic leukaemia (with maturation) |
|
C9208 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M0 | AML M0 |
|
C9208 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M1 | AML M1 |
|
C9208 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M2 | AML M2 |
|
C9208 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ (FABºÐ·ù¸¦ µ¿¹ÝÇÏÁö ¾ÊÀº) NOS | AML (without FAB) NOS |
|
C9208 | º¯ÇüµÈ ¸ð¼¼Æ÷°úÀ×À» µ¿¹ÝÇÑ ºÒÀÀ¼ººóÇ÷ | Refractory anaemia with excess blasts in transformation |
|